carbidopa and Muscular Atrophy

carbidopa has been researched along with Muscular Atrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amanova, ZN; Badalian, LO; Temin, PA1
Lang, AE1
Bressman, SB; Ford, B; Greene, PE; Hyland, K1

Reviews

1 review(s) available for carbidopa and Muscular Atrophy

ArticleYear
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4

    Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed

1995

Other Studies

2 other study(ies) available for carbidopa and Muscular Atrophy

ArticleYear
[Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
    Laboratornoe delo, 1984, Issue:11

    Topics: Adolescent; Adult; Carbidopa; Catecholamines; Child; Child, Preschool; Drug Combinations; Humans; Levodopa; Male; Muscular Atrophy; Muscular Dystrophies

1984
Parkinsonism, dystonia, and hemiatrophy.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3

    Topics: Adolescent; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Child; Child, Preschool; Dominance, Cerebral; Drug Therapy, Combination; Dystonia; Humans; Infant; Infant, Newborn; Levodopa; Magnetic Resonance Imaging; Muscular Atrophy; Neurologic Examination; Parkinson Disease; Putamen; Treatment Outcome

2000